hepatitis-c

Documents about hepatitis-c

• Assessment of Patients With Hepatitis C Virus Related Liver Cirrhosis After Sustained Response to Direct Acting Anti Viral Drugs.#811833ClinicalTrials.gov
• Grazoprevir (MK-5172) and Elbasvir (MK-8742) Combination in Treatment-Naïve Hepatitis C Virus Participants (MK-5172-067)#838415ClinicalTrials.gov
• Prevention of Disease Progress in Chronic Hepatitis C Patients With Liver Fibrosis (Study P02570AM2)(COMPLETED)#881878ClinicalTrials.gov
• A Trial to Reduce Hepatitis C Among Injection Drug Users - 1#887319ClinicalTrials.gov
• A Study of Mericitabine in Combination With Telaprevir and Peginterferon Alfa-2a / Ribavirin in Participants With Chronic Hepatitis C#892842ClinicalTrials.gov
• Influence of Ribavirin on the Initial Virological Response in Treatment Naïve Patients With Hepatitis C Genotype 1 Infection#904579ClinicalTrials.gov
• GS-7977 With Ribavirin for Hepatitis C (SPARE)#906738ClinicalTrials.gov
• Macrophage Activation Markers During Sofosbuvir-based Treatment Regimes of Chronic Hepatitis C#911504ClinicalTrials.gov
• Drug Interaction Study With Ribavirin and Abacavir in Male Subjects With Hepatitis C Who Have Failed Ribavirin Treatment#967147ClinicalTrials.gov
• Project I Test: Implementing HIV Testing in Opioid Treatment Programs#857110ClinicalTrials.gov
• Does Hepatitis C Management Protect Egyptian Population Against Severe Corona Virus Disease-2019?#918629ClinicalTrials.gov
• A Randomized Trial of Vaccine Adherence in Young Injection Drug Users#181591ClinicalTrials.gov
• An Efficacy, Safety, and Tolerability Study of TMC435 in Treatment-naive, Genotype 1 Hepatitis C-infected Patients#800602ClinicalTrials.gov
• An Efficacy, Safety, and Tolerability Study of TMC435 in Treatment-naive, Genotype 1 Hepatitis C-infected Participants#805379ClinicalTrials.gov
• High Dose Ribavirin in the Treatment of Chronic Hepatitis C#806937ClinicalTrials.gov
• 3-year Follow-up Study to Assess the Viral Activity in Hepatitis C Patients Who Failed Feeder DEB025/Alisporivir Study#827627ClinicalTrials.gov
• Liver Transplantation in Patients With Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Coinfection#831499ClinicalTrials.gov
• Study Assessing Single and Multiple Doses of IDX21459 in Healthy and HCV-Infected Subjects#877395ClinicalTrials.gov
• Sustained Virological Response (SVR)Rate of Pegasys Plus Ribavirin in Patients With Chronic Hepatitis C#892309ClinicalTrials.gov
• Efficacy of GZR/EBR in Early Chronic Hepatitis C in HIV/HCV Co-infected Patients#909107ClinicalTrials.gov
• Short Duration Combination Therapy With Daclatasvir, Asunaprevir, BMS-791325 and Sofosbuvir in Subjects Infected With Chronic Hepatitis-C (FOURward Study)#918408ClinicalTrials.gov
• A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1, 2, 4, 5 or 6 Infection and Compensated Cirrhosis#855943ClinicalTrials.gov
• HCV Reinfection in in HIV/HCV-coinfected Patients Achieving SVR by Antiviral Therapy#831606ClinicalTrials.gov
• Safety and Antiviral Activity of IDX184 in Combination With Pegylated Interferon and Ribavirin (MK-2355-004)#992514ClinicalTrials.gov
• Hepatitis B and C Within the Chinese Community in Milan#800771ClinicalTrials.gov
• Identification of Biomarkers Associated With Human Hepatocellular Carcinoma by SELDI#905080ClinicalTrials.gov
• Hepatitis C in Clinically Discordant Hemophilic Siblings#969270ClinicalTrials.gov
• Grazoprevir/Elbasvir for Genotype 1b Chronic Hepatitis C After Liver or Kidney Transplantation#807733ClinicalTrials.gov
• Study to Evaluate the Treatment for Chronic Hepatitis C With Normal Transaminases in HIV Positive Patients#831070ClinicalTrials.gov
• Anticoagulation in Liver Fibrosis in Patients With Hepatitis C Virus Infection#847799ClinicalTrials.gov
• Elimination of Hepatitis C Virus Among Users of Substances#854725ClinicalTrials.gov
• Pharmacist-led Hepatitis C Management#859889ClinicalTrials.gov
• Re-treatment of HCV Following DAA Failure#867097ClinicalTrials.gov
• An Observational Study of Peginterferon Alfa-2a in Combination With Ribavirin in Participants With Chronic Hepatitis C and Compensated Liver Cirrhosis#871991ClinicalTrials.gov
• Fluvastatin, Rosuvastatin Added to Pegylated Interferon and Ribavirin#872433ClinicalTrials.gov
• Efficacy Study of Mirtazapine to Treat Interferon-related Depression During Antiviral Therapy for Hepatitis C#891686ClinicalTrials.gov
• Effect of Harvoni on Proteinuria and eGFR in Hepatitis C Virus Associated Chronic Kidney Disease (CKD)#894840ClinicalTrials.gov
• An Open-label Randomized Multicenter Phase III Clinical Study Comparing Safety and Efficacy of Algeron (Cepeginterferon Alfa-2b) and and PegIntron (Peginterferon Alfa-2b) in Combination With Ribavirin as Combined Treatment of Chronic Hepatitis C in Human Immunodeficiency Virus-1 Infected Patients#884636ClinicalTrials.gov
• A Phase I/II Clinical Trial With Interferon Alfa 5 in Treatment-Experienced Patients With Genotype-1 Chronic Hepatitis C#859601ClinicalTrials.gov
• Study of the Role of Dendritic Cells in the Recurrence of Hepatitis C After Liver Transplantation. Analysis of Hepatitis C Virus (HCV) Quasispecies Evolution.#866803ClinicalTrials.gov
• A Study to Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Adults With Chronic Hepatitis C Virus (HCV) Genotype 2 Infection#908917ClinicalTrials.gov
• A Study to Evaluate the Safety and Efficacy of Celgosivir and Peginterferon Alfa-2b, With or Without Ribavirin, in Patients With Chronic Hepatitis C Genotype 1 Infection#968947ClinicalTrials.gov
• Global health sector strategies on HIV, viral hepatitis and sexually transmitted infections, 2022–2030: 2026 mid-term progress report#401516WHO IRIS
• Additional file 1 of Diagnostic capacity and utilization of Hepatitis B and C testing across multiple health care sectors in Vietnam#402224Figshare
• Risk Assessment of Long-Haul Truck Drivers#356556ClinicalTrials.gov
• Pioglitazone to Treat Fatty Liver in Patients With HIV and Hepatitis C Infections#245447ClinicalTrials.gov
• Evaluation of Safety, Tolerability, and Antiviral Activity of Chlorcyclizine HCl in Patients With Chronic Hepatitis C#377354ClinicalTrials.gov
• A Phase II Trial of Sofosbuvir (SOF) and GS-5816 for People With Chronic Hepatitis C Virus Infection and Recent Injection Drug Use#830456ClinicalTrials.gov
• A Health Intervention to Prevent Depression Hepatitis C Patients#832312ClinicalTrials.gov
• Adherence in Patients Receiving PegIntron Pen/Rebetol for Hepatitis C in Conjunction With a Patient Assistance Program (Study P04281)(COMPLETED)#846165ClinicalTrials.gov